Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-06

Clinical Trial Update: A Study of Topical Indigo Naturalis Treatment in Patients With Mild to Moderate Plaque-type Psoriasis [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 trial evaluating topical Indigo Naturalis for mild to moderate plaque-type psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Indigo Naturalis (Indigo naturalis)

Snippet

Sponsor: China Medical University Hospital | Conditions: Psoriasis | Phase 2 | Status: COMPLETED